CJC-1295 No DAC

Description

CJC-1295 No DAC : CJC-1295 — a 29-amino-acid GHRH analog research peptide optimized for in vitro studies of growth hormone regulation, IGF-1 signaling and metabolic energy pathways. This peptide contains a D-Ala in place of L-Ala for prolonged half-life and permits the examination of pulsatile GH release in carefully conducted in vitro research compounding studies without the protracted binding effects from DAC. Most commonly combined with Ipamorelin, CJC-1295 No DAC facilitates studies of synergistic effects on hormones, receptor crosstalk, and downstream metabolic signaling. All batches are provided in high purity peptides, COA verified peptides and third-party tested Peptide to ensure a reproducible result as well as reliable. HPLC-tested compounds and certificate of analysis peptide documentation enable US-based precise peptide synthesis and structured lab workflows. For research purposes only, this peptide fulfills the requirements of a 99% purity peptide vendor supplying pharmaceutical grade research chemicals, peptide bioregulators, and lyophilized peptide reconstitution. For Research Use Only. Not for Human Therapeutic or Diagnostic Use.